MedCurrent Updates Clinical Decision Support
CHICAGO-MedCurrent will feature at RSNA 2015 updates to its clinical decision support system.
MedCurrent will release at RSNA 2015 updates to MedCurrent CDS, a clinical decision support system.
The new system includes updated interfaces with deeper data analytics functionality that measures the system’s effectiveness and drives improvement initiatives, according to a release. An updated “Authoring Studio” provides the option to customize rules to meet local practice needs.
Appropriate Use criteria is used to analyze and rank the appropriateness of the provider’s order. The software provides feedback and informs the provider of the urgency in obtaining the study, the amount of radiation the patient will be exposed to, how expensive it is, and whether it has been performed recently, the release said.
The new system also allows two-way communication with the EMR, CPOE, scheduling, and other aligned systems, cross workflow compatibility to send orders through fax or e-mail and capacity for modular integration into PACS and RIS.
Visit MedCurrent at booth 2972.[[{"type":"media","view_mode":"media_crop","fid":"43691","attributes":{"alt":"","class":"media-image","id":"media_crop_920665902507","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4808","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 235px; width: 300px;","title":"MedCurrent Clinical Decision Support.","typeof":"foaf:Image"}}]]
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
